BioNexus Gene Lab Corp.
(BGLC) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
0.35
-5.41%
After-hours Jan 06, 2025, 07:56 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Net Income | -2.63M | -355.97K | 751.57K | 1.09M | -246.47K | 26.45K | -123.75K | -835 |
Depreciation & Amortization | 108.42K | 105.42K | 108.22K | 101.60K | 53.33K | 40.61K | 15.03K | n/a |
Stock-Based Compensation | 511.74K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -23.12K | -129.67K | 39.98K | 68.49K | -11.01K | -357.93K | n/a | n/a |
Other Non-Cash Items | 589.31K | -38.81K | 11.62K | -745.38K | 129.55K | 528.04K | -382.62K | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 117.98K | 833.38K | -862.25K | 102.36K | -24.14K | -341.14K | 439.31K | n/a |
Operating Cash Flow | -1.30M | 544.03K | 9.16K | 552.68K | -217.27K | -274.08K | 357.22K | -835 |
Capital Expenditures | -149.40K | -54.17K | -3.16K | -421.62K | -12.82K | -39.62K | -314.82K | n/a |
Acquisitions | n/a | n/a | n/a | 346.01K | n/a | n/a | -5.00M | n/a |
Purchase of Investments | -320.73K | -511.71K | -515.84K | -108.63K | n/a | -12.08K | n/a | n/a |
Sales Maturities Of Investments | 26.15K | n/a | 6.39K | 30.06K | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 61.41K | 115.38K | 22.04K | 1.47M | -12.82K | -12.08K | n/a | n/a |
Investing Cash Flow | -382.58K | -450.50K | -490.57K | 1.32M | -12.82K | -51.70K | -5.31M | n/a |
Debt Repayment | n/a | -34.04K | -26.30K | -4.95K | -16.78K | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | -115.38K | -22.04K | -6.31K | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5.75M | n/a | -1.92K | n/a | -164.03K | 742.94K | 5.78M | 638.00 |
Financial Cash Flow | 5.75M | 115.96K | -28.22K | -4.95K | -180.81K | 742.94K | 5.78M | 638.00 |
Net Cash Flow | 3.81M | -5.05K | -663.77K | 1.93M | -401.16K | 421.09K | 839.12K | -108 |
Free Cash Flow | -1.45M | 489.86K | 6.00K | 131.06K | -230.09K | -313.70K | 42.40K | -835 |